Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04711473 · ClinicalTrials.gov registry record · NA
Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 800
- Enrollment target
NCT04711473: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT04711473 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 800 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04711473, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
Study Summary
This is a 3-arm randomized trial aimed at increasing rates of participation in colorectal cancer (CRC) screening by outreach to patients' homes using choice architecture informed by behavioral science principles.
Primary Outcome
Screening completion rate in arm 2 (Choice) to arm 1 (Colonoscopy only) and arm 3 (FIT only) separately.
Interventions
- BEHAVIORAL Choice
- BEHAVIORAL Colonoscopy Only
- BEHAVIORAL FIT Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2021-10-27 |
| Est. Completion | 2022-11-11 |
| Phase | NA |
What the finished NCT04711473 record still lists
NCT04711473 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 3 interventions - of which Choice is the first listed.
NCT04711473 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04711473 about?
NCT04711473 is a clinical study titled "Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting". This is a 3-arm randomized trial aimed at increasing rates of participation in colorectal cancer (CRC) screening by outreach to patients' homes using choice architecture informed by behavioral science principles.
What is the current status of trial NCT04711473?
This trial is currently completed. It is a NA study. The enrollment target is 800 participants. The study started on 2021-10-27. Estimated completion is 2022-11-11.
What interventions are being tested in trial NCT04711473?
The interventions under investigation include: Choice (BEHAVIORAL), Colonoscopy Only (BEHAVIORAL), FIT Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT04711473?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04711473's enrollment target sits among peer trials
800 135th of 2000 higher than 1,861 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI